Nevertheless, it is possible that in addition to targeting DUX4, miR-675 could also target the ubiquitous USP10 protein in FSHD skeletal muscles, leading to a better outcome. The gene discussed is USP10; the disease is facioscapulohumeral muscular dystrophy.